Safety of perioperative hyperthermic intraperitoneal chemotherapy with gemcitabine in patients with resected pancreatic adenocarcinoma: a pilot study of the clinical trial EudraCT 2016-004298-41

BACKGROUND: Hyperthermic intraperitoneal chemotherapy (HIPEC) with gemcitabine, after cytoreductive surgery, may reduce the tumor progression of pancreatic cancer through the reduction of the neoplastic volume and the subpopulation of residual pancreatic cancer stem cells, improving the survival of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Gastrointest Oncol
Hauptverfasser: Padilla-Valverde, David, García-Santos, Esther, Sanchez, Susana, Manzanares, Carmen, Rodriguez, Marta, González, Lucia, Ambrós, Alfonso, Cano, Juana M., Serrano, Leticia, Bodoque, Raquel, Vergara, Teresa, Martin, Jesus
Format: Artigo
Sprache:Inglês
Veröffentlicht: AME Publishing Company 2021
Schlagworte:
Original Article on Pancreas Cancer
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100727/
https://ncbi.nlm.nih.gov/pubmed/33968428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-238
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge